Poland, Aug. 25 -- Poland based Gilead Sciences Poland Sp. z o.o. has secured contract from Uniwersyteckie Centrum Kliniczne for Antineoplastic Agents - 167/PN/2025 - Delivery of Axicabtagene Cilleucel for UCK. The value of the contract is worth 3751920000 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....